1. The FDA is Coming! The FDA is Coming!

   • G. B. Leonard Debra

   Editorial 14 December 2012 Pages: 153 - 154

2. Minimal Residual Disease:How Low Do We Go?

   • Adam Bagg

   Commentary 14 December 2012 Pages: 155 - 160

3. Detection of bcl-2/IgH Rearrangements by Quantitative-competitive PCR and Capillary Electrophoresis

   • Milhan Telatar
   • Wayne W. Grody
   • Christos Emmanouilides

   Original Research 14 December 2012 Pages: 161 - 168

4. Detection of Clonal T-cell Receptor γ Gene Rearrangements Using Fluorescent-based PCR and Automated High-resolution Capillary Electrophoresis

   • Vivian Luo
   • Stuart R. Lessin
   • Debra G. B. Leonard

   Original Research 14 December 2012 Pages: 169 - 179

5. Allelic Deletion Fingerprinting of Urine Cell Sediments in Bladder Cancer

   • Per C. M. Larsson
   • Ben Beheshti
   • Rob Shipman

   Original Research 14 December 2012 Pages: 181 - 188

6. Molecular Analysis of Congenital Adrenal Hyperplasia in a Newborn Screening Program

   • Anthony A. Killeen

   Original Reserch 14 December 2012 Pages: 189 - 191

7. Reverse Dot-blot Hybridization as an Improved Tool for the Molecular Diagnosis of Point Mutations in Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency

   • Y.-P. Yang
   • N. Corley
   • J. Garcia-Heras

   Original Research 14 December 2012 Pages: 193 - 199

8. Simultaneous Allele-specific Amplification: A Strategy Using Modified Primer-template Mismatches for SNP Detection—Application to Prothrombin 20210A (Factor II) and Factor V Leiden (1691A) Gene Mutations

   • Susie A. Delrio-Lafreniere
   • Ronald C. McGlennen

   Original Research 14 December 2012 Pages: 201 - 209

9. Clinical News Update

   • Richard D. Press

   OriginalPaper 14 December 2012 Pages: 211 - 213